866-997-4948(US-Canada Toll Free)

Strongyloidiasis Global Clinical Trials Review, H2, 2018

Published By :

GlobalData

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 36 Pages

Strongyloidiasis Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, Strongyloidiasis Global Clinical Trials Review, H2, 2018" provides an overview of Strongyloidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Strongyloidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Strongyloidiasis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Strongyloidiasis Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 34
Abbreviations 34
Definitions 34
Research Methodology 35
Secondary Research 35
About GlobalData 35
Contact Us 36
Disclaimer 36
Source 36

List of Tables
Strongyloidiasis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Strongyloidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Strongyloidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Strongyloidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Strongyloidiasis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Strongyloidiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Strongyloidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Strongyloidiasis Therapeutics, Global, Clinical Trials by Phase, 2018* 19
Strongyloidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Strongyloidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 21
Strongyloidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 22
Strongyloidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 23
Strongyloidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 24
Strongyloidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 25
Strongyloidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 26

List of Figures
Strongyloidiasis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Strongyloidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Strongyloidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11
Strongyloidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Strongyloidiasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
Proportion of Strongyloidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 15
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Strongyloidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 19
Strongyloidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Strongyloidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 21
Strongyloidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 22
Strongyloidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 23
Strongyloidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 24
Strongyloidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 25
Strongyloidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 26
GlobalData Methodology 35

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *